# REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)

> **NCT01875081** · PHASE2 · COMPLETED · sponsor: **Pharmicell Co., Ltd.** · enrollment: 72 (actual)

## Conditions studied

- Alcoholic Liver Cirrhosis

## Interventions

- **BIOLOGICAL:** Livercellgram

## Key facts

- **NCT ID:** NCT01875081
- **Lead sponsor:** Pharmicell Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2016-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01875081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01875081, "REVIVE(Randomized Exploratory Clinical Trial to Evaluate the Safety and Effectiveness of Stem Cell Product in Alcoholic Liver Cirrhosis Patient)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01875081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*